Computational discovery of SARS-CoV-2 viral entry inhibitory peptides from

Background and Objective: While vaccination remains central to controlling the COVID-19 pandemic, the emergence of SARS-CoV-2 variants with partial resistance to immune responses has highlighted the need for complementary therapeutic strategies. Among these, antiviral agents that inhibit viral entry mechanisms are of particular interest. Animal venoms, especially scorpion venoms, are a rich source of bioactive peptides with potential antiviral properties. This study aimed to evaluate peptides derived from the Moroccan scorpion Material and Methodology: Six peptides from the venom of the scorpion Results: Four peptides (AM1, AM3, AM4 and AM5) showed strong predicted antiviral activity (>85%). Docking identified AM5 as the most affinity ligand (ΔG = -14.0 kcal/mol), targeting the S2 fusion domain, followed by AM3 (allosteric mechanism), AM4 (targeting the furin cleavage site), and AM1 (specific RBD inhibitor). MD simulations revealed that AM1, AM3, and AM5 form structurally stable complexes (low and constant RMSD). In contrast, AM4 induces significant conformational instability (high and non-convergent RMSD) and overall decompaction. Thermodynamic analyses (FEL) confirm the superior stability of the AM3 and AM5 complexes. These results position AM5 as the most promising blocking candidate.